The House Energy and Commerce Health Subcommittee today concluded a two-day hearing on more than 30 bills to address the opioid crisis through Medicare and Medicaid coverage and payment policies, which follows a similar hearing last month on 25 other bills. Witnesses at the latest hearing included Michael Botticelli, executive director of the Grayken Center for Addiction at Boston Medical Center, and John Kravitz, chief information officer for Danville, PA-based Geisinger Health System. Botticelli, a former director of the White House Office of National Drug Control Policy and Massachusetts Bureau of Substance Addiction Services, emphasized the “critical role” that Medicaid plays in addressing the opioid epidemic. Kravitz described how the integrated health system has used electronic prescribing and information technology strategies to reduce opioid prescriptions, drug diversion and the cost of care. The Senate Health, Education, Labor and Pensions Committee yesterday held a hearing on a discussion draft of bipartisan legislation to address the opioid crisis, which the committee will mark up on April 24. 

Related News Articles

Headline
Commenting today on the Medicare Payment Advisory Commission’s draft recommendations for 2020, AHA said it supports the recommendation to provide current law…
Headline
The U.S. Supreme Court yesterday heard oral arguments in an appeal of a D.C. Circuit Court decision that the Department of Health and Human Services violated…
Headline
The Centers for Medicare…
Blog
AHA outside counsel Sean Marotta shares insight from yesterday’s oral arguments before the Supreme Court in a case about when the Department of Health and…
Headline
Continued rising drug prices, as well as shortages for many critical medications, are disrupting patient care and forcing hospitals to delay infrastructure and…
Headline
AHA said it generally supports CMS’ efforts to grant greater state-level flexibility and reduce regulatory burden, but urged the agency to ensure Medicaid…